AAFP director leaves for QI spin-off

Share this article:
Nancy Davis, PhD, has left her position as CME director of the American Academy of Family Physicians (AAFP) to become founding executive director of the National Institute for Quality Improvement in Education (NIQIE), a spin-off of  CE City.

NIQIE aims to close the CME-QI gap. Her replacement, Mindi McKenna, PhD, MBA, had been an assistant professor at Rockhurst University.

Davis, who was CME director since 2002, cited the academy’s leadership in seeing the “value and need for integrating quality and education,” an issue that has grown in importance since ACCME released updated accreditation criteria. Leaving the academy, she said, was an acknowledgement that “It’s really bigger than family medicine.”

While McKenna, whom Davis recruited, has never produced CME, Davis doesn’t see that as an obstacle: “They’ve got plenty of good people at the academy who can do that.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...